---
title: "ST SC Pharmaceuticals: Injectable Bivalirudin has obtained market approval from the Therapeutic Goods Administration (TGA) of Australia"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/238881223.md"
description: "ST SC Pharmaceuticals recently obtained marketing authorization from the Therapeutic Goods Administration (TGA) of Australia for injectable bivalirudin. This drug is used for the treatment of patients with moderate to high-risk acute coronary syndrome, applicable to those with unstable angina and non-ST elevation myocardial infarction, and can be used in combination with aspirin and P2Y12 antagonists"
datetime: "2025-05-06T10:10:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/238881223.md)
  - [en](https://longbridge.com/en/news/238881223.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/238881223.md)
---

# ST SC Pharmaceuticals: Injectable Bivalirudin has obtained market approval from the Therapeutic Goods Administration (TGA) of Australia

According to the Zhitong Finance APP, \*ST Pharmaceuticals (002693.SZ) announced that the company recently received the marketing authorization for injectable bivalirudin issued by the Therapeutic Goods Administration (TGA) of Australia.

It is reported that injectable bivalirudin is used as an anticoagulant for the treatment of patients with moderate to high-risk acute coronary syndrome (ACS) (unstable angina/non-ST elevation myocardial infarction (UA/NSTEMI) who are undergoing early invasive treatment, as well as patients undergoing percutaneous coronary intervention (PCI). Injectable bivalirudin is intended to be used in conjunction with aspirin. Additionally, it can be used in combination with P2Y12 antagonists (such as clopidogrel or ticagrelor)

### Related Stocks

- [002693.CN](https://longbridge.com/en/quote/002693.CN.md)

## Related News & Research

- [China closing in but US leads in biotech quality, commercial reach, survey finds](https://longbridge.com/en/news/290470794.md)
- [Energy Update - Morning Express - Blue Line Futures](https://longbridge.com/en/news/290717025.md)
- [14:53 ETAbu Dhabi eröffnet durch eine Partnerschaft mit Biocom einen strategischen Life-Sciences-Korridor nach Kalifornien](https://longbridge.com/en/news/290729392.md)
- [New report finds few sunscreens meet safety standards](https://longbridge.com/en/news/290736186.md)
- [REG - Cambridge Cognition - Retail Offer](https://longbridge.com/en/news/290649828.md)